What׳s the role of sirolimus on the treatment of lymphangioleiomyomatosis (LAM)?: Merely tuning up of LAM-associated dysfunctional lymphatic vessels rather than cytoreduction?
- PMID: 24998376
- DOI: 10.1016/j.resinv.2014.02.004
What׳s the role of sirolimus on the treatment of lymphangioleiomyomatosis (LAM)?: Merely tuning up of LAM-associated dysfunctional lymphatic vessels rather than cytoreduction?
Comment on
-
Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis.Respir Investig. 2013 Sep;51(3):175-83. doi: 10.1016/j.resinv.2013.03.002. Epub 2013 May 30. Respir Investig. 2013. PMID: 23978644
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
